At a glance
- Originator Takeda
- Class Antifungals
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 17 Jan 2003 No development reported - Preclinical for Mycoses in Japan (Parenteral)
- 26 Sep 2000 Preclinical development for Mycoses in Japan (Parenteral)